Daan Dierickx, G Verhoef, A Van Hoof, P Mineur, A Roest, A Triffet, A Kentos, P Pierre, D Boulet, G Bries, P-Q Lê, A Janssens, A Delannoy
OBJECTIVES: For better characterizing the effect of anti-CD20 therapy, we analysed the use of rituximab in Belgian patients experiencing auto-immune haemolytic anaemia (AIHA) and immune thrombocytopenic purpura (ITP). DESIGN: We performed a retrospective multicentric analysis of patients with AIHA and ITP treated with rituximab in Belgium. SETTING: Haematological departments were invited to fill in a questionnaire about patient and disease characteristics...
November 2009: Journal of Internal Medicine